Dale Cooke (@PhillyCooke) header
Dale Cooke (@PhillyCooke) profile picture

Following FDA regulations and healthcare

Philly
Joined April 2008
Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)Photo by Dale Cooke (@PhillyCooke)
Hey @Amtrak the app is getting worse. Not the time in the screenshot
Hey @Amtrak not exactly the most helpful to have the app failing to inform me the train is delayed 7 minutes after departure when it still hasn’t boarded
1
1
Hey @Amtrak not exactly the most helpful to have the app failing to inform me the train is delayed 7 minutes after departure when it still hasn’t boarded
1
1
Wrapping up @foodanddruglaw #adpromo22. Thanks for following the discussion! See you next year!
1
3
Priorities fr @DOJCivil & @DOJCrimDiv in deciding on moving off-label cases forward
1
Raqiyyah Pippins of @arnoldporter on alternate paths of enforcement such as @TruthinAd & class action lawsuits #adpromo22
Philomena McArthur of @JNJGlobalHealth notes that reviewers’ job is sometimes to tell people their baby is ugly. #adpromo22
1
#adpromo22 session on preventing fraud & abuse b/c well… read the slide.
Rich Cleland of @FTC notes no one ever gets fined for making a disclosure they didn’t need to. #adpromo22
Dara Levy of @fdalawblog notes that WV took state action for consumer fraud based solely on an FDA letter. #adpromo22
LinkedIn represents the greatest enforcement risk in the EU for #adpromo22
Alan Minsk of @agglaw giving us more ESG & a bit of history rock music
1
Katherine Rogers of @KelleyDryeAdLaw on ESG trends in advertising #adpromo22
Mark Gaydos of ⁦@sanofi⁩ making clear some of the risks of ⁦@US_FDA⁩ #Opdp enforcement beyond the letter for prep arrival promotion
1
1
Wayne Pines of @apcoworldwide kicking off the #adpromo22 session on preapproval promo. Notes the obvious point: during height of the pandemic, we saw more extensive public discussion of products under investigation than we typically do & if this should change our views now
Dale Cooke retweeted
Calling all student members! Join us on October 19, 1:00-2:00 PM ET for #CareersOverCoffee - a complimentary, exclusive opportunity to engage in facilitated virtual discussions about different career paths in the FDA-regulated products fields. bit.ly/3e09YBs
1
1
#opdp updated process to post close out letters for Warning & untitled letters #adpromo22
1
2
When @US_FDA proposed the rule they noted 33% of ads they reviewed against the new standard failed to meet the proposed standard. #adpromo22 so implementing CCN as proposed would likely affect loads of ads…unless industry practice is very different from 2010